Research output per year
Research output per year
Search results
-
2024
Efficacy and safety of pembrolizumab and radiotherapy in relapsed/ refractory cutaneous T cell lymphoma: results of the PORT trial
Morris, S., Scarisbrick, J., Arumainathan, A., Bates, A., Cheadle, E., Collins, G., Cowan, R., El-Mehidi, N., O'Rourke, N., Osbourne, W., Pawade, J., Robinson, S., Tyson, C., Ward, J., Whittaker, S., Wilson, W. & Illidge, T., Oct 2024, In: European Journal of Cancer. 211, p. S22-S23 2 p., 114386.Research output: Contribution to journal › Meeting Abstract › peer-review